Their conclusion that the Biden administration overestimated the risk of escalation underestimates just how hard it is to ...

The same research team that documented the impact of auto-enrollment and auto-escalation in 401(k) plans has returned to the ...

Context Therapeutics has dosed the first subject in the Phase I trial of CTIM-76, targeting gynaecologic and testicular cancers.

Former MDining employees at the University of Michigan allege identity-based harassment, isolation and a flawed grievance ...

Multifamily developments are vital to solving the region's housing shortage, but Phoenix and its suburban cities are at odds ...

Aspen Neuroscience, Inc. has successfully completed dose escalation and the first two cohorts of patients in the ASPIRO study, an ANPD001 Phase 1/2a clinical trial in Parkinson's Disease (PD).

The new mental-health policy explicitly promotes diversion to non-law-enforcement agencies and addresses those with severe ...

Verismo Therapeutics has commenced the first patient dosing in its multicentre Phase I CELESTIAL-301 trial of SynKIR-310.

UK garment suppliers are seeing a significant surge in business optimism heading into 2025, after a report shows growth in Q3 2024.